Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer

Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer

The prostate cancer (PCa) field lacks clinically relevant, syngeneic mouse models which retain the tumour microenvironment observed in PCa patients. This study establishes a cell line from prostate tumour tissue derived from the <i>Pten<sup>−/−</sup>/trp53<sup>−/−</sup>...

Full description

Bibliographic Details
Main Authors:	Charles M. Haughey, Debayan Mukherjee, Rebecca E. Steele, Amy Popple, Lara Dura-Perez, Adam Pickard, Mehjabin Patel, Suneil Jain, Paul B. Mullan, Rich Williams, Pedro Oliveira, Niamh E. Buckley, Jamie Honeychurch, Simon S. McDade, Timothy Illidge, Ian G. Mills, Sharon L. Eddie
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Cancers
Subjects:	tumour microenvironment syngeneic model prostate cancer radiotherapy preclinical modelling myeloid-derived suppressor cells
Online Access:	https://www.mdpi.com/2072-6694/12/10/2804

Similar Items

A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
by: Tuxiong Huang, et al.
Published: (2020-07-01)

Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model
by: Yakkundi P, et al.
Published: (2019-04-01)

Biogenicity and Syngeneity of Organic Matter in Ancient Sedimentary Rocks: Recent Advances in the Search for Evidence of Past Life
by: Dorothy Z. Oehler, et al.
Published: (2014-08-01)

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
by: Wenyan Zhong, et al.
Published: (2020-01-01)

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
by: Jessica Castrillon Lal, et al.
Published: (2021-08-01)

Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
by: Cameron N. Johnstone, et al.
Published: (2015-03-01)

MHC-Linked Syngeneic Developmental Preference inThymic Lobes Colonized with Bone Marrow Cells: A Mathematical model
by: Amiela Globerson, et al.
Published: (1998-01-01)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
by: Jenna N. Regan, et al.
Published: (2017-12-01)

Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment
by: Daniel T. Doty, et al.
Published: (2020-09-01)

Application of immunotherapy based on dendritic cells stimulated by tumor cell-derived exosomes in a syngeneic breast tumor mouse model
by: Yin Ji Piao, et al.
Published: (2021-12-01)

A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain
by: Jung Won Hwang, et al.
Published: (2020-04-01)

Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes
by: Caroline Spenlé, et al.
Published: (2021-07-01)

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model
by: Amy L. Wilson, et al.
Published: (2021-01-01)

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
by: Molly A. Taylor, et al.
Published: (2019-11-01)

IDENTIFICATION OF PARAMECIUM BURSARIA SYNGENS THROUGH MOLECULAR MARKERS – COMPARATIVE ANALYSIS OF MITOCHONDRIAL CYTOCHROME C OXIDASE SUBUNIT I (COI)
by: Patrycja Zagata, et al.
Published: (2014-08-01)

Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis
by: Aadya Nagpal, et al.
Published: (2019-08-01)

Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d
by: Takashi Semba, et al.
Published: (2020-12-01)

A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors
by: Barbara Costa, et al.
Published: (2021-01-01)

Einfluss CD4+CD25+ regulatorischer T-Zellen auf die hämatopoetische Rekonstitution nach syngener und allogener Stammzelltransplantation in einem dreifach transgenen Mausmodell
by: Rothe, Katherina
Published: (2011)

The Complex Role of Autophagy in Melanoma Evolution: New Perspectives From Mouse Models
by: Luca Di Leo, et al.
Published: (2020-01-01)

Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib
by: Sami Znati, et al.
Published: (2020-07-01)

Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model
by: Kenta Tsunekuni, et al.
Published: (2020-12-01)

Implantable orthotopic bladder cancer model in Wistar rats: A pilot and feasibility study
by: Teke Kerem, et al.
Published: (2019-01-01)

Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host
by: Ute Jungwirth, et al.
Published: (2018-01-01)

Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
by: Ramya Sivakumar, et al.
Published: (2019-12-01)

Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
by: Bernice Nounamo, et al.
Published: (2017-09-01)

Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
by: Qiang Li, et al.
Published: (2020-02-01)

Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
by: Elad eJacoby, et al.
Published: (2014-05-01)

An experimental model of anti-PD-1 resistance exhibits activation of TGFß and Notch pathways and is sensitive to local mRNA immunotherapy
by: Marie Bernardo, et al.
Published: (2021-01-01)

The design, analysis and application of mouse clinical trials in oncology drug development
by: Sheng Guo, et al.
Published: (2019-07-01)

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
by: Razia Zakarya, et al.
Published: (2020-07-01)

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
by: Yvonne Grobben, et al.
Published: (2021-01-01)

Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice
by: Masashi Izumiya, et al.
Published: (2021-05-01)

SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
by: Christine Naczki, et al.
Published: (2018-10-01)

Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
by: Soo-Hyun Kim, et al.
Published: (2018-07-01)

Comparison of responsiveness to cancer development and anti-cancer drug in three different C57BL/6N stocks
by: Mi Ju Kang, et al.
Published: (2019-10-01)

Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
by: Inoru Yokoe, et al.
Published: (2021-01-01)

The chondrodystrophic dog: A clinically relevant intermediate‐sized animal model for the study of intervertebral disc‐associated spinal pain
by: Kelly Thompson, et al.
Published: (2018-03-01)

Pain: A Review of Interleukin-6 and Its Roles in the Pain of Rheumatoid Arthritis
by: Sebba A
Published: (2021-03-01)

Comparative evaluation of two suturing models for preclinical training
by: Triveni Kale, et al.
Published: (2019-01-01)